Dr. Steven Mandel & Sam Mandel: The Efficacy of Ketamine Infusion Therapy

Dr. Steven Mandel & Sam Mandel: The Efficacy of Ketamine Infusion Therapy

A hot topic in the world of psychedelic medicine is whether ketamine infusion therapy is as effective as ketamine-assisted therapy (also called KAP). Today’s guests Dr. Steven Mandel and his son Sam Mandel have administered over 13,000 treatments at their Los Angeles-based clinic and they are passionate about the power of intravenous ketamine treatment.

On the show we discuss the efficacy of IV ketamine therapy and how it compares to intramuscular as a route of administration. We talk about Dr. Mandel’s specific protocol including the use of a pump instead of a drip bag for administration. We cover the potential health concerns around ketamine and finish as always with advice to psychedelic therapists.

Dr. Steven Mandel has more than 40 years of experience utilizing ketamine as a board-certified anesthesiologist and has a master’s degree in psychology. He is the co-founder and president of Ketamine Clinics Los Angeles, and the co-founder of American Society of Ketamine Physicians, Psychotherapists and Practitioners.

Sam Mandel is co-founder and chief operating officer of Ketamine Clinics Los Angeles. A mental health advocate and entrepreneur, he oversees all non-clinical functions of the company and has been active in the ketamine infusion therapy community since its formative days.

LINKS

TIMESTAMPS

  • :05 - How Dr. Mendel and his son Sam started the Ketamine Clinics of Los Angeles
  • :09 - Should psychedelic practitioners receive the treatment themselves?
  • :16 - How ketamine functions in the brain
  • :23 - Is ketamine infusion therapy as effective as psychedelic-assisted talk therapy?
  • :32 - Intervenus vs Intramuscular ketamine
  • :39 - Dr. Mandel’s ketamine protocol
  • :46 - How do you assess the effectiveness of ketamine therapy?
  • :54 - Potential issues with ketamine use: addiction, bladder damage, or cognitive impairment.
  • 1:08 - Dr. Steven and Sam Mandel share their advice

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(64)

Ismail Lourido Ali (MAPS): The Work No Executive Order Can Do

Ismail Lourido Ali (MAPS): The Work No Executive Order Can Do

"We can pass 10 executive orders. We can put $500 million for drug development. And if we don't have people who are willing to hold that space... we're not going to get anywhere." - Ismail Lourido Ali...

21 Apr 1h 10min

Robin Arnott & Sandeep Prakash: Training for Psychedelic Surrender

Robin Arnott & Sandeep Prakash: Training for Psychedelic Surrender

Can we practice the art of surrender before the first dose?Today on the show Robin Arnott and Dr. Sandeep Prakash explain how SoundSelf evolved from a VR curiosity into a clinically oriented tool that...

25 Apr 202555min

Joshua White: Who You Gonna Call? Fireside

Joshua White: Who You Gonna Call? Fireside

Imagine you’re in the middle of a psychedelic journey—things are getting intense, and you just need someone to talk to. That’s whereFireside Project comes in. As the world’s first psychedelic peer sup...

13 Feb 20251h 14min

Tom Feegel: Ibogaine for Cognitive Enhancement

Tom Feegel: Ibogaine for Cognitive Enhancement

A month ago, I had the privilege of visiting Beond in Cancun, Mexico to experience an ibogaine treatment for cognitive enhancement. Today, I’m joined by Beond CEO Tom Feegel to discuss how this remark...

27 Jan 20251h 6min

Juan Pablo Capello: A Wakeup Call for Ketamine Telehealth Companies

Juan Pablo Capello: A Wakeup Call for Ketamine Telehealth Companies

Today, I’m joined by Juan Pablo Capello, co-founder and former CEO of New Life Health, a telehealth ketamine therapy service launched in 2021. Juan Pablo has raised concerns about low standards of car...

20 Nov 20241h 4min

Natalie Lyla Ginsberg (MAPS): The FDA, MDMA, and the Future of Psychedelic Therapy

Natalie Lyla Ginsberg (MAPS): The FDA, MDMA, and the Future of Psychedelic Therapy

Today, we’re exploring a critical issue facing the field of psychedelic medicine: the recent FDA rejection of MAPS’ clinical trials to reschedule MDMA for therapeutic use. This setback affects many of...

28 Okt 20241h 3min

Tricia Eastman & Joseph Barsuglia: Ibogaine is Miracle Grow for the Brain

Tricia Eastman & Joseph Barsuglia: Ibogaine is Miracle Grow for the Brain

Today we’re doing something a little different. I’m re-releasing an episode from my personal podcast, Life is a Festival, because it remains one of my favorite interviews ever. This conversation, orig...

18 Okt 20241h 9min

Jennifer Tippett: Understanding Private Practice vs Clinical Trials

Jennifer Tippett: Understanding Private Practice vs Clinical Trials

After the shocking decision of an advisory committee recommendation that the FDA reject MDMA as a treatment for post-traumatic stress disorder, I wanted to speak to someone who understands the differe...

8 Aug 202446min

Populært innen Helse

fastlegen
rss-gukild-johaug
hvordan-har-du-det-mann
psykodrama
lydartikler-fra-aftenposten
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-skravla-gar
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
foreldreradet
rss-garne-damer
morten-ramm-lar-kakla-ga-til-du-sovner
hjernesterk
klimaks
g-punktet
rss-lopedrommen
rss-loping-for-nybegynnere
helsetipspodden
rss-kunsten-a-leve
kjed-deg-i-sovn-verdens-kjedeligste-podcast